← Back to home

Recurrent diffuse large B-cell lymphoma associated with chronic inflammation

Clinical trials for Recurrent diffuse large B-cell lymphoma associated with chronic inflammation explained in plain language.

Never miss a new study

Get alerted when new Recurrent diffuse large B-cell lymphoma associated with chronic inflammation trials appear

Sign up with your email to follow new studies for Recurrent diffuse large B-cell lymphoma associated with chronic inflammation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New combo may help more lymphoma patients reach potentially curative CAR-T

Disease control Recruiting now

This study tests whether giving two drugs, golcadomide and rituximab, before CAR-T cell therapy can help control aggressive B-cell non-Hodgkin lymphoma that has returned or not responded to prior treatment. The goal is to keep the disease in check so more patients can qualify for…

Matched conditions: RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED WITH CHRONIC INFLAMMATION

Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

Recurrent diffuse large B-cell lymphoma associated with chronic inflammation

Get alerted when new Recurrent diffuse large B-cell lymphoma associated with chronic inflammation trials appear

New combo may help more lymphoma patients reach potentially curative CAR-T